BIONEXUS GENE LAB CORP (BGLC) Stock Cash Flow
NASDAQ:BGLC - Nasdaq - US0906283066 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -1.60M | -2.63M | -360.00K | 750.00K | 1.09M | |||
| Depreciation Amortization | 104.20K | 83.30K | 90.00K | 90.00K | 90.00K | |||
| Change In Working Capital | 115.40K | 118.00K | 830.00K | -860.00K | 100.00K | |||
| Interest Paid | 9.40K | 13.90K | 10.00K | 10.00K | 10.00K | |||
| Taxes Paid | 40.40K | 67.00K | 170.00K | 230.00K | 130.00K | |||
| Other non cash items | -855.50K | 1.13M | -20.00K | 30.00K | -730.00K | |||
| OPERATING CASH FLOW | -2.23M | -1.30M | 540.00K | 10.00K | 550.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -227.00K | -149.40K | -50.00K | 0.00 | -420.00K | |||
| Other Investing Activity | 645.20K | -233.20K | -400.00K | -490.00K | 1.74M | |||
| INVESTING CASH FLOW | 418.20K | -382.60K | -450.00K | -490.00K | 1.32M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -30.00K | -30.00K | 0.00 | |||
| Stock Issued/Repurchased | 141.00K | 5.75M | 150.00K | N/A | 0.00 | |||
| Other Financing Activity | 4.00K | 4.30K | 0.00 | 0.00 | 0.00 | |||
| FINANCING CASH FLOW | 145.00K | 5.75M | 120.00K | -30.00K | 0.00 | |||
| Exchange Rate Effect | 40.30K | -259.70K | -210.00K | -150.00K | 60.00K | |||
| CHANGE IN CASH | -1.63M | 3.81M | 0.00 | -660.00K | 1.93M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -2.23M | -1.30M | 540.00K | 10.00K | 550.00K | |||
| Capital Expenditure | -227.00K | -149.40K | -50.00K | 0.00 | -420.00K | |||
| FREE CASH FLOW | -2.46M | -1.45M | 490.00K | 10.00K | 130.00K | |||
All data in USD